Chudova Darya 4
4 · Guardant Health, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CTO Darya Chudova Receives Award
What Happened Darya Chudova, Chief Technology Officer of Guardant Health (GH), was granted 23,856 restricted stock units (RSUs) on March 11, 2026. The RSUs were granted at $0.00 (no cash paid) and are recorded as a derivative award; there was no immediate sale or purchase of shares.
Key Details
- Transaction date: March 11, 2026; Form 4 filed March 13, 2026. No late filing indication in the report.
- Grant: 23,856 RSUs; reported price $0.00 (derivative award), reported value $0 at grant.
- Vesting: 33% of the award vests April 1, 2027; the remaining 67% vests in equal quarterly installments over the two years thereafter (three-year total vesting period). (Footnote F1)
- Footnote F2: Not applicable for Restricted Stock Units.
- Shares owned after transaction: Not specified in the filing.
Context This was a time-based equity award (RSUs), not an open-market purchase or sale. RSUs typically convert to actual shares only as they vest and may be subject to company withholding for taxes; such future vesting/withholding events would be reported separately when they occur. Awards are routine compensation for executives and do not, by themselves, indicate buying or selling sentiment.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-03-11+23,856→ 23,856 totalExercise: $0.00→ Common Stock (23,856 underlying)
Footnotes (2)
- [F1]This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F2]Not applicable for Restricted Stock Units.